Schueller, Olivier
Kadmon Corporation (United States)
2 papers on CoChatORCID 0009-0000-1534-0903
Most cited papers
- Verified
Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
Zanin-Zhorov, A., Weiss, J. M., Nyuydzefe, M. S., Chen, W., Scher, J. U., Mo, R., Depoil, D., Rao, N., Liu, B., Wei, J., et al. (2014) · Proceedings of the National Academy of Sciences
Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology
Cited by 262
- Verified
ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease
Jagasia, M., Lazaryan, A., Bachier, C. R., Salhotra, A., Weisdorf, D. J., Zoghi, B., Essell, J., Green, L., Schueller, O., Patel, J., et al. (2021) · Journal of Clinical Oncology
Hematopoietic Stem Cell TransplantationImmunodeficiency and Autoimmune Disorders
Cited by 198
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free